LIVE: Reuters Newsmaker with Lars Fruergaard Jørgensen, CEO of Novo Nordisk

  Рет қаралды 3,326

Reuters

Reuters

11 ай бұрын

Novo Nordisk is the first drugmaker to introduce a highly effective weight-loss drug, Wegovy, at a time of record obesity rates.
Lars Fruergaard Jørgensen, CEO of Novo Nordisk, discusses with Reuters Breakingviews columnist Aimee Donnellan the challenge of rapidly ramping up production of Wegovy to meet soaring demand for the breakthrough drug.

#LarsFruergaardJørgensen #NovoNordisk #Wegovy AimeeDonnellan #ReutersNewsmaker #Reuters #Live #News #business #finance

Пікірлер
The CEO Behind Ozempic, Wegovy and Europe's Most Valuable Company
24:07
Bloomberg Television
Рет қаралды 3,4 М.
Alex hid in the closet #shorts
00:14
Mihdens
Рет қаралды 14 МЛН
НРАВИТСЯ ЭТОТ ФОРМАТ??
00:37
МЯТНАЯ ФАНТА
Рет қаралды 7 МЛН
Looks realistic #tiktok
00:22
Анастасия Тарасова
Рет қаралды 106 МЛН
Senate Committee Holds Hearing on Making Insulin Affordable in the U.S.
3:06:41
Eli Lilly CEO on Fighting Obesity, Developing New Drugs
7:46
Bloomberg Television
Рет қаралды 1,9 М.
How Ozempic Could Break Denmark's Economy
9:31
TLDR Business
Рет қаралды 175 М.
How Employers Could Be Spying On You While Working From Home
14:59
One of the Greatest Speeches Ever | Steve Jobs
10:31
Motivation Ark
Рет қаралды 34 МЛН